Investing.com -- Amid a highly contentious merger process marked by rampant opposition, the deciding shareholder meeting in STAAR Surgical’s (NASDAQ:STAA) $1.6 billion sale to Alcon AG (NYSE:ALC) has ...
Background: To use a Monte Carlo simulation to predict postoperative results with the AcrySof ® Toric lens, evaluating the likelihood of over- or under-correction using various toric lens selection ...
Alcon Inc.'s acquisition of LENSAR, Inc. remains pending, with an FTC antitrust review likely delaying the closing. LNSR shareholders overwhelmingly approved the $14.00/share cash deal, with a ...
The eyes of the market now turn to January 6th. If Alcon and the STAAR Board cannot bridge the 20-point gap in shareholder support over the holiday break, the merger, and the future leadership of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback